Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.19.3
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2019
Jun. 30, 2019
Current assets:    
Cash $ 107,058 $ 30,142
Accounts receivable - net 181,053 45,086
Inventories 437,022 406,439
Other current assets 133,083 1,000
Total current assets 858,216 482,667
Total assets 858,216 482,667
Current liabilities:    
Accounts payable 149,323 496,809
Accrued expense-related party 21,974 33,974
Convertible notes payable - net of discount 1,367,106 1,117,741
Fair value of derivative liabilities 1,748,849 1,306,748
Total current liabilities 3,287,252 2,955,272
Commitments and contingencies
Stockholders' deficit:    
Preferred stock, ($0.001 par value, 100,000,000 shares authorized, and 1,000 issued and outstanding as of September 30, 2019 and 1,000 outstanding as of June 30, 2019, respectively) 1 1
Common stock, ($0.001 par value, 200,000,000 shares authorized, and 55,416,371 issued and outstanding as of September 30, 2019 and 53,773,856 outstanding as of June 30, 2019, respectively) 55,416 53,774
Additional paid in capital 11,317,770 10,692,679
Accumulated deficit (13,802,223) (13,219,059)
Total stockholders' deficit (2,429,036) (2,472,605)
Total Liabilities and Stockholders' Deficit $ 858,216 $ 482,667